Sep 16, 2020 / 01:30PM GMT
Vikram Purohit - Morgan Stanley, Research Division - Equity Analyst
Okay. Great. Welcome, everyone. My name is Vikram Purohit. I'm one of the biotech analysts with Morgan Stanley Research, and we are here for a fireside chat with the management team from Incyte. I have on the line with me Hervé Hoppenot and Christiana Stamoulis, CEO and CFO of Incyte. Welcome to both of you.
HervéHoppenot - Incyte Corporation - Chairman, President & CEO
Thank you. Good morning.
Christiana Stamoulis - Incyte Corporation - Executive VP & CFO
Good morning, Vikram.
Vikram Purohit - Morgan Stanley, Research Division - Equity Analyst
Good morning. Before we go ahead and get started with the discussion, I need to read a brief disclaimer. Please note that this webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For
Incyte Corp at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot